SANA PHARMA MEDICAL AS

1366 LYSAKER

Finances

Return on Equity

−5,58 %

Current Ratio

0,89

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	61 707 000	63 534 000	56 050 000	39 235 000
Net Income	−803 000	2 271 000	1 839 000	−1 408 000
Total Assets	47 077 000	32 057 000	30 140 000	26 512 000
Total Equity	14 387 000	14 623 000	12 352 000	10 513 000

Income (NOK)	2022	2021	2020	2019
Revenue	61 707 000	63 534 000	56 050 000	39 235 000
Expenditure	61 506 000	57 989 000	53 972 000	40 190 000
Operating Profit	200 000	5 546 000	2 078 000	−955 000
Financial Income	184 000	1 000	456 000	371 000
Financial Costs	1 047 000	3 276 000	695 000	823 000
Financial Balance	−863 000	−3 275 000	−239 000	−452 000
Earnings Before Tax	−664 000	2 271 000	1 839 000	−1 408 000
Tax	139 000	0	0	0
Net Income	−803 000	2 271 000	1 839 000	−1 408 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	18 129 000	3 695 000	1 611 000	999 000
Total Current Assets	28 948 000	28 361 000	28 529 000	25 512 000
Total Assets	47 077 000	32 057 000	30 140 000	26 512 000
Total Retained Equity	3 874 000	4 110 000	1 839 000	0
Total Equity	14 387 000	14 623 000	12 352 000	10 513 000
Total Long-Term Debt	0	0	0	0
Total Current Debt	32 690 000	17 434 000	17 788 000	15 999 000
Total Equity and Debt	47 077 000	32 057 000	30 140 000	26 512 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	61 703 000	63 534 000	56 050 000	39 235 000
Other Income	4 000	0	0	0
Revenue	61 707 000	63 534 000	56 050 000	39 235 000
Cost of Goods Sold	19 586 000	18 360 000	14 250 000	9 051 000
Salary Costs	13 810 000	11 638 000	7 877 000	7 087 000
Depreciation	684 000	472 000	0	0
Impairment	0	0	66 000	0
Expenditure	61 506 000	57 989 000	53 972 000	40 190 000
Operating Profit	200 000	5 546 000	2 078 000	−955 000
Financial Income	184 000	1 000	456 000	371 000
Financial Costs	1 047 000	3 276 000	695 000	823 000
Financial Balance	−863 000	−3 275 000	−239 000	−452 000
Dividends	0	0	0	0
Net Income	−803 000	2 271 000	1 839 000	−1 408 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	14 171 000	850 000	678 000	66 000
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	1 486 000	1 867 000	0	0
Total Tangible Assets	1 486 000	1 867 000	0	0
Total Fiancial Fixed Assets	2 473 000	978 000	933 000	933 000
Total Fixed Assets	18 129 000	3 695 000	1 611 000	999 000
Stock	8 439 000	8 785 000	7 841 000	6 110 000
Total Investments	0	0	0	0
Cash, Bank	4 806 000	7 394 000	390 000	294 000
Total Current Assets	28 948 000	28 361 000	28 529 000	25 512 000
Total Assets	47 077 000	32 057 000	30 140 000	26 512 000
Total Equity	14 387 000	14 623 000	12 352 000	10 513 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	0	0	0	0
Creditors	3 457 000	10 346 000	5 130 000	3 941 000
Unpaid Taxes	2 698 000	2 812 000	2 491 000	1 755 000
Dividends	0	0	0	0
Other Current Debt	12 056 000	1 011 000	1 999 000	4 692 000
Total Current Debt	32 690 000	17 434 000	17 788 000	15 999 000
Total Equity and Debt	47 077 000	32 057 000	30 140 000	26 512 000

Financial indicators	2022	2021	2020	2019
Return on Equity	−5,58 %	15,53 %	14,89 %	−13,39 %
Debt-to-Equity Ratio	0	0	0	0
Operating Profit Margin	0,32 %	8,73 %	3,71 %	−2,43 %
Current Ratio	0,89	1,63	1,6	1,59
Quick Ratio	1,19	3,28	2,87	2,58
Equity Ratio	0,31	0,46	0,41	0,4
Gross Profit Margin	68,26 %	71,1 %	74,58 %	76,93 %